SEC Company Response from REGENTIS BIOMATERIALS LTD. (RGNT) (CIK 0001912966) (RGNT) — Sep 8, 2025
REGENTIS BIOMATERIALS LTD. (RGNT) (CIK 0001912966)
Date: Sept. 8, 2025 · CIK: 0001912966 · Accession: 0001213900-25-085647
AI Filing Summary & Sentiment
File numbers found in text: 333-285692
Show Raw Text
CORRESP
1
filename1.htm
Regentis Biomaterials Ltd.
60 Medinat Hyahudim
Hertzliya, Israel 4676652
September 8, 2025
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
RE:
Regentis Biomaterials Ltd. (CIK 0001912966)
Registration Statement No. 333-285692 on Form F-1 (the “Registration Statement”)
Ladies and Gentlemen:
Regentis Biomaterials Ltd.
(the “Registrant”) hereby requests acceleration of the effectiveness of the above-referenced Registration Statement
pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), so that it may become effective
on September 10, 2025 at 5:00 p.m., Eastern Time, or as soon thereafter as is practicable.
The undersigned respectfully
requests that it be notified of the effectiveness of the Registration Statement by telephone call to our counsel, Greenberg Traurig, P.A.,
by calling David Huberman at 312.364.1633. The Company hereby authorizes Mr. Huberman to orally modify or withdraw this request for acceleration.
Very truly yours,
REGENTIS BIOMATERIALS LTD.
By:
/s/ Dr. Eli Hazum
Dr. Eli Hazum
Chief Executive Officer